Global Anti-Cancer Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
According to our (Global Info Research) latest study, the global Anti-Cancer Drug market size was valued at USD 86710 million in 2022 and is forecast to a readjusted size of USD 110520 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
This report is a detailed and comprehensive analysis for global Anti-Cancer Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-Cancer Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Cancer Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Cancer Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Cancer Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-Cancer Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-Cancer Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Bristol-Myers Squibb, Bayer, GlaxoSmithKline and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Anti-Cancer Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Anti-Cancer Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-Cancer Drug, with price, sales, revenue and global market share of Anti-Cancer Drug from 2018 to 2023.
Chapter 3, the Anti-Cancer Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Cancer Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-Cancer Drug.
Chapter 14 and 15, to describe Anti-Cancer Drug sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Anti-Cancer Drug market size was valued at USD 86710 million in 2022 and is forecast to a readjusted size of USD 110520 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.
Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
This report is a detailed and comprehensive analysis for global Anti-Cancer Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-Cancer Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Cancer Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Cancer Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Cancer Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-Cancer Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-Cancer Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Bristol-Myers Squibb, Bayer, GlaxoSmithKline and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Anti-Cancer Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Avastin
- Rituxan
- Herceptin
- Alimta
- Hospital
- Clinic
- Home Care
- Merck
- Bristol-Myers Squibb
- Bayer
- GlaxoSmithKline
- Novartis
- Sanofi
- Pfizer
- Amgen
- Celgene Corporation
- Ariad Pharmaceuticals
- Eli Lilly
- Hoffmann-La Roche Ltd.
- AstraZeneca
- Boehringer Ingelheim GmbH
- Teva Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Anti-Cancer Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-Cancer Drug, with price, sales, revenue and global market share of Anti-Cancer Drug from 2018 to 2023.
Chapter 3, the Anti-Cancer Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Cancer Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-Cancer Drug.
Chapter 14 and 15, to describe Anti-Cancer Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Anti-Cancer Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-Cancer Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Avastin
1.3.3 Rituxan
1.3.4 Herceptin
1.3.5 Alimta
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-Cancer Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Home Care
1.5 Global Anti-Cancer Drug Market Size & Forecast
1.5.1 Global Anti-Cancer Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-Cancer Drug Sales Quantity (2018-2029)
1.5.3 Global Anti-Cancer Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Anti-Cancer Drug Product and Services
2.1.4 Merck Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Anti-Cancer Drug Product and Services
2.2.4 Bristol-Myers Squibb Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bristol-Myers Squibb Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Anti-Cancer Drug Product and Services
2.3.4 Bayer Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Recent Developments/Updates
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Anti-Cancer Drug Product and Services
2.4.4 GlaxoSmithKline Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Anti-Cancer Drug Product and Services
2.5.4 Novartis Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Anti-Cancer Drug Product and Services
2.6.4 Sanofi Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Anti-Cancer Drug Product and Services
2.7.4 Pfizer Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Anti-Cancer Drug Product and Services
2.8.4 Amgen Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Amgen Recent Developments/Updates
2.9 Celgene Corporation
2.9.1 Celgene Corporation Details
2.9.2 Celgene Corporation Major Business
2.9.3 Celgene Corporation Anti-Cancer Drug Product and Services
2.9.4 Celgene Corporation Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Celgene Corporation Recent Developments/Updates
2.10 Ariad Pharmaceuticals
2.10.1 Ariad Pharmaceuticals Details
2.10.2 Ariad Pharmaceuticals Major Business
2.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Product and Services
2.10.4 Ariad Pharmaceuticals Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ariad Pharmaceuticals Recent Developments/Updates
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Anti-Cancer Drug Product and Services
2.11.4 Eli Lilly Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Eli Lilly Recent Developments/Updates
2.12 Hoffmann-La Roche Ltd.
2.12.1 Hoffmann-La Roche Ltd. Details
2.12.2 Hoffmann-La Roche Ltd. Major Business
2.12.3 Hoffmann-La Roche Ltd. Anti-Cancer Drug Product and Services
2.12.4 Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Anti-Cancer Drug Product and Services
2.13.4 AstraZeneca Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 AstraZeneca Recent Developments/Updates
2.14 Boehringer Ingelheim GmbH
2.14.1 Boehringer Ingelheim GmbH Details
2.14.2 Boehringer Ingelheim GmbH Major Business
2.14.3 Boehringer Ingelheim GmbH Anti-Cancer Drug Product and Services
2.14.4 Boehringer Ingelheim GmbH Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boehringer Ingelheim GmbH Recent Developments/Updates
2.15 Teva Pharmaceuticals
2.15.1 Teva Pharmaceuticals Details
2.15.2 Teva Pharmaceuticals Major Business
2.15.3 Teva Pharmaceuticals Anti-Cancer Drug Product and Services
2.15.4 Teva Pharmaceuticals Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Teva Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-CANCER DRUG BY MANUFACTURER
3.1 Global Anti-Cancer Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-Cancer Drug Revenue by Manufacturer (2018-2023)
3.3 Global Anti-Cancer Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-Cancer Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-Cancer Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-Cancer Drug Manufacturer Market Share in 2022
3.5 Anti-Cancer Drug Market: Overall Company Footprint Analysis
3.5.1 Anti-Cancer Drug Market: Region Footprint
3.5.2 Anti-Cancer Drug Market: Company Product Type Footprint
3.5.3 Anti-Cancer Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-Cancer Drug Market Size by Region
4.1.1 Global Anti-Cancer Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-Cancer Drug Consumption Value by Region (2018-2029)
4.1.3 Global Anti-Cancer Drug Average Price by Region (2018-2029)
4.2 North America Anti-Cancer Drug Consumption Value (2018-2029)
4.3 Europe Anti-Cancer Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-Cancer Drug Consumption Value (2018-2029)
4.5 South America Anti-Cancer Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-Cancer Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-Cancer Drug Sales Quantity by Type (2018-2029)
5.2 Global Anti-Cancer Drug Consumption Value by Type (2018-2029)
5.3 Global Anti-Cancer Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-Cancer Drug Sales Quantity by Application (2018-2029)
6.2 Global Anti-Cancer Drug Consumption Value by Application (2018-2029)
6.3 Global Anti-Cancer Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Anti-Cancer Drug Sales Quantity by Type (2018-2029)
7.2 North America Anti-Cancer Drug Sales Quantity by Application (2018-2029)
7.3 North America Anti-Cancer Drug Market Size by Country
7.3.1 North America Anti-Cancer Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-Cancer Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Anti-Cancer Drug Sales Quantity by Type (2018-2029)
8.2 Europe Anti-Cancer Drug Sales Quantity by Application (2018-2029)
8.3 Europe Anti-Cancer Drug Market Size by Country
8.3.1 Europe Anti-Cancer Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-Cancer Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-Cancer Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-Cancer Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-Cancer Drug Market Size by Region
9.3.1 Asia-Pacific Anti-Cancer Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-Cancer Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Anti-Cancer Drug Sales Quantity by Type (2018-2029)
10.2 South America Anti-Cancer Drug Sales Quantity by Application (2018-2029)
10.3 South America Anti-Cancer Drug Market Size by Country
10.3.1 South America Anti-Cancer Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-Cancer Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-Cancer Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-Cancer Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-Cancer Drug Market Size by Country
11.3.1 Middle East & Africa Anti-Cancer Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-Cancer Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Anti-Cancer Drug Market Drivers
12.2 Anti-Cancer Drug Market Restraints
12.3 Anti-Cancer Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-Cancer Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-Cancer Drug
13.3 Anti-Cancer Drug Production Process
13.4 Anti-Cancer Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-Cancer Drug Typical Distributors
14.3 Anti-Cancer Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Anti-Cancer Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-Cancer Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Avastin
1.3.3 Rituxan
1.3.4 Herceptin
1.3.5 Alimta
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-Cancer Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Home Care
1.5 Global Anti-Cancer Drug Market Size & Forecast
1.5.1 Global Anti-Cancer Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-Cancer Drug Sales Quantity (2018-2029)
1.5.3 Global Anti-Cancer Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Anti-Cancer Drug Product and Services
2.1.4 Merck Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Anti-Cancer Drug Product and Services
2.2.4 Bristol-Myers Squibb Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bristol-Myers Squibb Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Anti-Cancer Drug Product and Services
2.3.4 Bayer Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Recent Developments/Updates
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Anti-Cancer Drug Product and Services
2.4.4 GlaxoSmithKline Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GlaxoSmithKline Recent Developments/Updates
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Anti-Cancer Drug Product and Services
2.5.4 Novartis Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Anti-Cancer Drug Product and Services
2.6.4 Sanofi Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Anti-Cancer Drug Product and Services
2.7.4 Pfizer Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Anti-Cancer Drug Product and Services
2.8.4 Amgen Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Amgen Recent Developments/Updates
2.9 Celgene Corporation
2.9.1 Celgene Corporation Details
2.9.2 Celgene Corporation Major Business
2.9.3 Celgene Corporation Anti-Cancer Drug Product and Services
2.9.4 Celgene Corporation Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Celgene Corporation Recent Developments/Updates
2.10 Ariad Pharmaceuticals
2.10.1 Ariad Pharmaceuticals Details
2.10.2 Ariad Pharmaceuticals Major Business
2.10.3 Ariad Pharmaceuticals Anti-Cancer Drug Product and Services
2.10.4 Ariad Pharmaceuticals Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Ariad Pharmaceuticals Recent Developments/Updates
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Anti-Cancer Drug Product and Services
2.11.4 Eli Lilly Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Eli Lilly Recent Developments/Updates
2.12 Hoffmann-La Roche Ltd.
2.12.1 Hoffmann-La Roche Ltd. Details
2.12.2 Hoffmann-La Roche Ltd. Major Business
2.12.3 Hoffmann-La Roche Ltd. Anti-Cancer Drug Product and Services
2.12.4 Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Anti-Cancer Drug Product and Services
2.13.4 AstraZeneca Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 AstraZeneca Recent Developments/Updates
2.14 Boehringer Ingelheim GmbH
2.14.1 Boehringer Ingelheim GmbH Details
2.14.2 Boehringer Ingelheim GmbH Major Business
2.14.3 Boehringer Ingelheim GmbH Anti-Cancer Drug Product and Services
2.14.4 Boehringer Ingelheim GmbH Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boehringer Ingelheim GmbH Recent Developments/Updates
2.15 Teva Pharmaceuticals
2.15.1 Teva Pharmaceuticals Details
2.15.2 Teva Pharmaceuticals Major Business
2.15.3 Teva Pharmaceuticals Anti-Cancer Drug Product and Services
2.15.4 Teva Pharmaceuticals Anti-Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Teva Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTI-CANCER DRUG BY MANUFACTURER
3.1 Global Anti-Cancer Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-Cancer Drug Revenue by Manufacturer (2018-2023)
3.3 Global Anti-Cancer Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-Cancer Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-Cancer Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-Cancer Drug Manufacturer Market Share in 2022
3.5 Anti-Cancer Drug Market: Overall Company Footprint Analysis
3.5.1 Anti-Cancer Drug Market: Region Footprint
3.5.2 Anti-Cancer Drug Market: Company Product Type Footprint
3.5.3 Anti-Cancer Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Anti-Cancer Drug Market Size by Region
4.1.1 Global Anti-Cancer Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-Cancer Drug Consumption Value by Region (2018-2029)
4.1.3 Global Anti-Cancer Drug Average Price by Region (2018-2029)
4.2 North America Anti-Cancer Drug Consumption Value (2018-2029)
4.3 Europe Anti-Cancer Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-Cancer Drug Consumption Value (2018-2029)
4.5 South America Anti-Cancer Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-Cancer Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Anti-Cancer Drug Sales Quantity by Type (2018-2029)
5.2 Global Anti-Cancer Drug Consumption Value by Type (2018-2029)
5.3 Global Anti-Cancer Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Anti-Cancer Drug Sales Quantity by Application (2018-2029)
6.2 Global Anti-Cancer Drug Consumption Value by Application (2018-2029)
6.3 Global Anti-Cancer Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Anti-Cancer Drug Sales Quantity by Type (2018-2029)
7.2 North America Anti-Cancer Drug Sales Quantity by Application (2018-2029)
7.3 North America Anti-Cancer Drug Market Size by Country
7.3.1 North America Anti-Cancer Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-Cancer Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Anti-Cancer Drug Sales Quantity by Type (2018-2029)
8.2 Europe Anti-Cancer Drug Sales Quantity by Application (2018-2029)
8.3 Europe Anti-Cancer Drug Market Size by Country
8.3.1 Europe Anti-Cancer Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-Cancer Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Anti-Cancer Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-Cancer Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-Cancer Drug Market Size by Region
9.3.1 Asia-Pacific Anti-Cancer Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-Cancer Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Anti-Cancer Drug Sales Quantity by Type (2018-2029)
10.2 South America Anti-Cancer Drug Sales Quantity by Application (2018-2029)
10.3 South America Anti-Cancer Drug Market Size by Country
10.3.1 South America Anti-Cancer Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-Cancer Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Anti-Cancer Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-Cancer Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-Cancer Drug Market Size by Country
11.3.1 Middle East & Africa Anti-Cancer Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-Cancer Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Anti-Cancer Drug Market Drivers
12.2 Anti-Cancer Drug Market Restraints
12.3 Anti-Cancer Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Anti-Cancer Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-Cancer Drug
13.3 Anti-Cancer Drug Production Process
13.4 Anti-Cancer Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-Cancer Drug Typical Distributors
14.3 Anti-Cancer Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Anti-Cancer Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-Cancer Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Anti-Cancer Drug Product and Services
Table 6. Merck Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Major Business
Table 10. Bristol-Myers Squibb Anti-Cancer Drug Product and Services
Table 11. Bristol-Myers Squibb Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bristol-Myers Squibb Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Anti-Cancer Drug Product and Services
Table 16. Bayer Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bayer Recent Developments/Updates
Table 18. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Anti-Cancer Drug Product and Services
Table 21. GlaxoSmithKline Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GlaxoSmithKline Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Anti-Cancer Drug Product and Services
Table 26. Novartis Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi Anti-Cancer Drug Product and Services
Table 31. Sanofi Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanofi Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Anti-Cancer Drug Product and Services
Table 36. Pfizer Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Amgen Basic Information, Manufacturing Base and Competitors
Table 39. Amgen Major Business
Table 40. Amgen Anti-Cancer Drug Product and Services
Table 41. Amgen Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Amgen Recent Developments/Updates
Table 43. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Corporation Major Business
Table 45. Celgene Corporation Anti-Cancer Drug Product and Services
Table 46. Celgene Corporation Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Celgene Corporation Recent Developments/Updates
Table 48. Ariad Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Ariad Pharmaceuticals Major Business
Table 50. Ariad Pharmaceuticals Anti-Cancer Drug Product and Services
Table 51. Ariad Pharmaceuticals Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Ariad Pharmaceuticals Recent Developments/Updates
Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 54. Eli Lilly Major Business
Table 55. Eli Lilly Anti-Cancer Drug Product and Services
Table 56. Eli Lilly Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Hoffmann-La Roche Ltd. Major Business
Table 60. Hoffmann-La Roche Ltd. Anti-Cancer Drug Product and Services
Table 61. Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 63. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 64. AstraZeneca Major Business
Table 65. AstraZeneca Anti-Cancer Drug Product and Services
Table 66. AstraZeneca Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca Recent Developments/Updates
Table 68. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 69. Boehringer Ingelheim GmbH Major Business
Table 70. Boehringer Ingelheim GmbH Anti-Cancer Drug Product and Services
Table 71. Boehringer Ingelheim GmbH Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 73. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceuticals Major Business
Table 75. Teva Pharmaceuticals Anti-Cancer Drug Product and Services
Table 76. Teva Pharmaceuticals Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceuticals Recent Developments/Updates
Table 78. Global Anti-Cancer Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Anti-Cancer Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Anti-Cancer Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 81. Market Position of Manufacturers in Anti-Cancer Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Anti-Cancer Drug Production Site of Key Manufacturer
Table 83. Anti-Cancer Drug Market: Company Product Type Footprint
Table 84. Anti-Cancer Drug Market: Company Product Application Footprint
Table 85. Anti-Cancer Drug New Market Entrants and Barriers to Market Entry
Table 86. Anti-Cancer Drug Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Anti-Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Anti-Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Anti-Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Anti-Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Anti-Cancer Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 92. Global Anti-Cancer Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 93. Global Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Anti-Cancer Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Anti-Cancer Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Anti-Cancer Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 98. Global Anti-Cancer Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 99. Global Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Anti-Cancer Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Anti-Cancer Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Anti-Cancer Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Anti-Cancer Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 105. North America Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Anti-Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Anti-Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Anti-Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Anti-Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Anti-Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Anti-Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Anti-Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Anti-Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Anti-Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Anti-Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Anti-Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Anti-Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Anti-Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Anti-Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Anti-Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Anti-Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Anti-Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Anti-Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Anti-Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Anti-Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Anti-Cancer Drug Raw Material
Table 146. Key Manufacturers of Anti-Cancer Drug Raw Materials
Table 147. Anti-Cancer Drug Typical Distributors
Table 148. Anti-Cancer Drug Typical Customers
Table 1. Global Anti-Cancer Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-Cancer Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Anti-Cancer Drug Product and Services
Table 6. Merck Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Major Business
Table 10. Bristol-Myers Squibb Anti-Cancer Drug Product and Services
Table 11. Bristol-Myers Squibb Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bristol-Myers Squibb Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Anti-Cancer Drug Product and Services
Table 16. Bayer Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bayer Recent Developments/Updates
Table 18. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Anti-Cancer Drug Product and Services
Table 21. GlaxoSmithKline Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GlaxoSmithKline Recent Developments/Updates
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Anti-Cancer Drug Product and Services
Table 26. Novartis Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi Anti-Cancer Drug Product and Services
Table 31. Sanofi Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanofi Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Anti-Cancer Drug Product and Services
Table 36. Pfizer Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Amgen Basic Information, Manufacturing Base and Competitors
Table 39. Amgen Major Business
Table 40. Amgen Anti-Cancer Drug Product and Services
Table 41. Amgen Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Amgen Recent Developments/Updates
Table 43. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Corporation Major Business
Table 45. Celgene Corporation Anti-Cancer Drug Product and Services
Table 46. Celgene Corporation Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Celgene Corporation Recent Developments/Updates
Table 48. Ariad Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Ariad Pharmaceuticals Major Business
Table 50. Ariad Pharmaceuticals Anti-Cancer Drug Product and Services
Table 51. Ariad Pharmaceuticals Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Ariad Pharmaceuticals Recent Developments/Updates
Table 53. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 54. Eli Lilly Major Business
Table 55. Eli Lilly Anti-Cancer Drug Product and Services
Table 56. Eli Lilly Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Hoffmann-La Roche Ltd. Major Business
Table 60. Hoffmann-La Roche Ltd. Anti-Cancer Drug Product and Services
Table 61. Hoffmann-La Roche Ltd. Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 63. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 64. AstraZeneca Major Business
Table 65. AstraZeneca Anti-Cancer Drug Product and Services
Table 66. AstraZeneca Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca Recent Developments/Updates
Table 68. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 69. Boehringer Ingelheim GmbH Major Business
Table 70. Boehringer Ingelheim GmbH Anti-Cancer Drug Product and Services
Table 71. Boehringer Ingelheim GmbH Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 73. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceuticals Major Business
Table 75. Teva Pharmaceuticals Anti-Cancer Drug Product and Services
Table 76. Teva Pharmaceuticals Anti-Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceuticals Recent Developments/Updates
Table 78. Global Anti-Cancer Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Anti-Cancer Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Anti-Cancer Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 81. Market Position of Manufacturers in Anti-Cancer Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Anti-Cancer Drug Production Site of Key Manufacturer
Table 83. Anti-Cancer Drug Market: Company Product Type Footprint
Table 84. Anti-Cancer Drug Market: Company Product Application Footprint
Table 85. Anti-Cancer Drug New Market Entrants and Barriers to Market Entry
Table 86. Anti-Cancer Drug Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Anti-Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Anti-Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Anti-Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Anti-Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Anti-Cancer Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 92. Global Anti-Cancer Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 93. Global Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Anti-Cancer Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Anti-Cancer Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Anti-Cancer Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 98. Global Anti-Cancer Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 99. Global Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Anti-Cancer Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Anti-Cancer Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Anti-Cancer Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 104. Global Anti-Cancer Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 105. North America Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Anti-Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Anti-Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Anti-Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Anti-Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Anti-Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Anti-Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Anti-Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Anti-Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Anti-Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Anti-Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Anti-Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Anti-Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Anti-Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Anti-Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Anti-Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Anti-Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Anti-Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Anti-Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Anti-Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Anti-Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Anti-Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Anti-Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Anti-Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Anti-Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Anti-Cancer Drug Raw Material
Table 146. Key Manufacturers of Anti-Cancer Drug Raw Materials
Table 147. Anti-Cancer Drug Typical Distributors
Table 148. Anti-Cancer Drug Typical Customers
LIST OF FIGURES
Figure 1. Anti-Cancer Drug Picture
Figure 2. Global Anti-Cancer Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-Cancer Drug Consumption Value Market Share by Type in 2022
Figure 4. Avastin Examples
Figure 5. Rituxan Examples
Figure 6. Herceptin Examples
Figure 7. Alimta Examples
Figure 8. Global Anti-Cancer Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Anti-Cancer Drug Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Home Care Examples
Figure 13. Global Anti-Cancer Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Anti-Cancer Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Anti-Cancer Drug Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Anti-Cancer Drug Average Price (2018-2029) & (USD/Unit)
Figure 17. Global Anti-Cancer Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Anti-Cancer Drug Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Anti-Cancer Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Anti-Cancer Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Anti-Cancer Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Anti-Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Anti-Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Anti-Cancer Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Anti-Cancer Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 32. Global Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Anti-Cancer Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Anti-Cancer Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 35. North America Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Anti-Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Anti-Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Anti-Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Anti-Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Anti-Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Anti-Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 55. China Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Anti-Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Anti-Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Anti-Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Anti-Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Anti-Cancer Drug Market Drivers
Figure 76. Anti-Cancer Drug Market Restraints
Figure 77. Anti-Cancer Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Anti-Cancer Drug in 2022
Figure 80. Manufacturing Process Analysis of Anti-Cancer Drug
Figure 81. Anti-Cancer Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Anti-Cancer Drug Picture
Figure 2. Global Anti-Cancer Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-Cancer Drug Consumption Value Market Share by Type in 2022
Figure 4. Avastin Examples
Figure 5. Rituxan Examples
Figure 6. Herceptin Examples
Figure 7. Alimta Examples
Figure 8. Global Anti-Cancer Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Anti-Cancer Drug Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Home Care Examples
Figure 13. Global Anti-Cancer Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Anti-Cancer Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Anti-Cancer Drug Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Anti-Cancer Drug Average Price (2018-2029) & (USD/Unit)
Figure 17. Global Anti-Cancer Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Anti-Cancer Drug Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Anti-Cancer Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Anti-Cancer Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Anti-Cancer Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Anti-Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Anti-Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Anti-Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Anti-Cancer Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Anti-Cancer Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 32. Global Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Anti-Cancer Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Anti-Cancer Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 35. North America Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Anti-Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Anti-Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Anti-Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Anti-Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Anti-Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Anti-Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 55. China Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Anti-Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Anti-Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Anti-Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Anti-Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Anti-Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Anti-Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Anti-Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Anti-Cancer Drug Market Drivers
Figure 76. Anti-Cancer Drug Market Restraints
Figure 77. Anti-Cancer Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Anti-Cancer Drug in 2022
Figure 80. Manufacturing Process Analysis of Anti-Cancer Drug
Figure 81. Anti-Cancer Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
